Novel immunological strategies for islet transplantation

Pharmacological Research

Volumn 98, Issue , 2015, Pages 69-75

  Tezza, Sara ^a,b,e   Ben Nasr, Moufida ^a,b   Vergani, Andrea ^b,c   Valderrama Vasquez, Alessandro ^b   Maestroni, Anna ^b   Abdi, Reza ^a   Secchi, Antonio ^b,d   Fiorina, Paolo ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Dompé Inc   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Costimulatory molecules; Encapsulation; Immune therapies; Immunosuppression; Islet transplantation; Type 1 diabetes; Xenograft

Indexed keywords

ALEMTUZUMAB; CD3 ANTIBODY; CD34 ANTIGEN; INTERLEUKIN 8; REPARIXIN; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

CELL ENCAPSULATION; CLINICAL TRIAL (TOPIC); COSTIMULATORY PATHWAY; DENDRITIC CELL; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; XENOGRAFT; ANIMAL; AUTOTRANSPLANTATION; DIABETES MELLITUS, TYPE 1; IMMUNOLOGY; PIG; PROCEDURES;

ANIMALS; DIABETES MELLITUS, TYPE 1; HETEROGRAFTS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; TRANSPLANTATION, AUTOLOGOUS;

EID: 84930761844     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.06.016     Document Type: Review

References (82)

1. Z.T. Bloomgarden Diabetes complications Diabetes Care 27 2004 1506 1514
2. Z.T. Bloomgarden Glycemic treatment: control of glycemia Diabetes Care 27 2004 1227 1234
3. A.M. Shapiro, J.R. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, and G.L. Warnock Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 2000 230 238
4. A.M. Shapiro, C. Ricordi, B.J. Hering, H. Auchincloss, R. Lindblad, and R.P. Robertson International trial of the edmonton protocol for islet transplantation N Engl J Med 355 2006 1318 1330
5. P. Fiorina, F. Folli, F. Bertuzzi, P. Maffi, G. Finzi, and M. Venturini Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients Diabetes Care 26 2003 1129 1136
6. P. Fiorina, A.M. Shapiro, C. Ricordi, and A. Secchi The clinical impact of islet transplantation Am J Transplant 8 2008 1990 1997
7. B.J. Hering, C.C. Browatzki, A. Schultz, R.G. Bretzel, and K.F. Federlin Clinical islet transplantation - registry report, accomplishments in the past and future research needs Cell Transplant 2 1993 269 282 discussion 283-305
8. F.B. Barton, M.R. Rickels, R. Alejandro, B.J. Hering, S. Wease, and B. Naziruddin Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 35 2012 1436 1445
9. K.K. Papas, T. Karatzas, T. Berney, T. Minor, P. Pappas, and F. Pattou International workshop: islet transplantation without borders enabling islet transplantation in greece with international collaboration and innovative technology Clin Transplant 27 2013 E116 E125
10. G.L. Warnock, D.M. Thompson, R.M. Meloche, R.J. Shapiro, Z. Ao, and P. Keown A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes Transplantation 86 2008 1762 1766
11. G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, and T. Canu Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study J Am Coll Cardiol 46 2005 1085 1092
12. R. Paroni, I. Fermo, P. Fiorina, and G. Cighetti Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects Amino Acids 28 2005 389 394
13. F. Folli, V. Guzzi, L. Perego, D.K. Coletta, G. Finzi, and C. Placidi Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation PLoS ONE 5 2010 e9923
14. M. Venturini, P. Fiorina, P. Maffi, C. Losio, A. Vergani, and A. Secchi Early increase of retinal arterial and venous blood flow velocities at color doppler imaging in brittle type 1 diabetes after islet transplant alone Transplantation 81 2006 1274 1277
15. L. Makhlouf, K. Kishimoto, R.N. Smith, R. Abdi, M. Koulmanda, and H.J. Winn The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade Diabetes 51 2002 3202 3210
16. C. Ricordi, and T.B. Strom Clinical islet transplantation: advances and immunological challenges Nat Rev Immunol 4 2004 259 268
17. B.J. Hering, M. Wijkstrom, M.L. Graham, M. Hardstedt, T.C. Aasheim, and T. Jie Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Nat Med 12 2006 301 303
18. K. Cardona, G.S. Korbutt, Z. Milas, J. Lyon, J. Cano, and W. Jiang Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways Nat Med 12 2006 304 306
19. S.S. Lin, M.J. Hanaway, G.V. Gonzalez-Stawinski, C.L. Lau, W. Parker, and R.D. Davis The role of anti-galalpha1-3gal antibodies in acute vascular rejection and accommodation of xenografts Transplantation 70 2000 1667 1674
20. G. Chen, H. Qian, T. Starzl, H. Sun, B. Garcia, and X. Wang Acute rejection is associated with antibodies to non-gal antigens in baboons using gal-knockout pig kidneys Nat Med 11 2005 1295 1298
21. K. Kuwaki, Y.L. Tseng, F.J. Dor, A. Shimizu, S.L. Houser, and T.M. Sanderson Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience Nat Med 11 2005 29 31
22. G.R. Rayat, R.V. Rajotte, B.J. Hering, T.M. Binette, and G.S. Korbutt In vitro and in vivo expression of galalpha-(1,3)gal on porcine islet cells is age dependent J Endocrinol 177 2003 127 135
23. N. Kirchhof, S. Shibata, M. Wijkstrom, D.M. Kulick, C.T. Salerno, and S.M. Clemmings Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection Xenotransplantation 11 2004 396 407
24. M.L. Graham, and H.J. Schuurman The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival Xenotransplantation 20 2013 5 17
25. S. Schneider, P.J. Feilen, F. Brunnenmeier, T. Minnemann, H. Zimmermann, and U. Zimmermann Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice Diabetes 54 2005 687 693
26. T. Kobayashi, Y. Aomatsu, H. Iwata, T. Kin, H. Kanehiro, and M. Hisanga Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of nod mice Cell Transplant 15 2006 359 365
27. A. Omer, V. Duvivier-Kali, J. Fernandes, V. Tchipashvili, C.K. Colton, and G.C. Weir Long-term normoglycemia in rats receiving transplants with encapsulated islets Transplantation 79 2005 52 58
28. M. de Groot, T.A. Schuurs, and R. van Schilfgaarde Causes of limited survival of microencapsulated pancreatic islet grafts J Surg Res 121 2004 141 150
29. D. Jacobs-Tulleneers-Thevissen, M. Chintinne, Z. Ling, P. Gillard, L. Schoonjans, and G. Delvaux Beta cell therapy consortium E-F, sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient Diabetologia 56 2013 1605 1614
30. R. Calafiore, G. Basta, G. Luca, A. Lemmi, M.P. Montanucci, and G. Calabrese Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases Diabetes Care 29 2006 137 138
31. B.E. Tuch, G.W. Keogh, L.J. Williams, W. Wu, J.L. Foster, and V. Vaithilingam Safety and viability of microencapsulated human islets transplanted into diabetic humans Diabetes Care 32 2009 1887 1889
32. G. Basta, P. Montanucci, G. Luca, C. Boselli, G. Noya, and B. Barbaro Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases Diabetes Care 34 2011 2406 2409
33. B. Ludwig, A. Reichel, A. Steffen, B. Zimerman, A.V. Schally, and N.L. Block Transplantation of human islets without immunosuppression Proc Natl Acad Sci U S A 110 2013 19054 19058
34. F. Claas Chimerism as a tool to induce clinical transplantation tolerance Curr Opin Immunol 16 2004 578 583
35. Z. Guo, T. Wu, H. Sozen, Y. Pan, N. Heuss, and H. Kalscheuer A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice Transplantation 75 2003 909 915
36. P. Fiorina, M. Jurewicz, A. Vergani, A. Petrelli, M. Carvello, and F. D'Addio Targeting the cxcr4-cxcl12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 J Immunol 186 2011 121 131
37. B. Nikolic, Y. Takeuchi, I. Leykin, Y. Fudaba, R.N. Smith, and M. Sykes Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity Diabetes 53 2004 376 383
38. Y. Reisner, E. Bachar-Lustig, H.W. Li, F. Aversa, A. Velardi, and M.F. Martelli The role of megadose cd34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation Ann N Y Acad Sci 872 1999 336 348 discussion 348-350
39. Y. Reisner, H. Gur, S. Reich-Zeliger, M.F. Martelli, and E. Bachar-Lustig Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose cd34 cells and other veto cells Ann N Y Acad Sci 996 2003 72 79
40. H. Gur, R. Krauthgamer, E. Bachar-Lustig, H. Katchman, R. Arbel-Goren, and A. Berrebi Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha Blood 105 2005 2585 2593
41. F. D'Addio, A. Valderrama Vasquez, M. Ben Nasr, E. Franek, D. Zhu, and L. Li Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis Diabetes 2014
42. A.C. Farney, E. Xenos, D.E. Sutherland, M. Widmer, E. Stephanian, and M.J. Field Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor Transplant Proc 25 1993 865 866
43. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, W. Reinisch, A. Olson, and J. Johanns Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
44. D.L. Scott, and G.H. Kingsley Tumor necrosis factor inhibitors for rheumatoid arthritis N Engl J Med 355 2006 704 712
45. B. Gala-Lopez, T. Kin, D. O'Gorman, A.R. Pepper, P. Senior, and A. Humar Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection Diabetes Technol Ther 15 2013 323 327
46. P. Maffi, F. Bertuzzi, F. De Taddeo, P. Magistretti, R. Nano, and P. Fiorina Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy Diabetes Care 30 2007 1150 1155
47. P.J. Morris, and N.K. Russell Alemtuzumab (campath-1 h): a systematic review in organ transplantation Transplantation 81 2006 1361 1367
48. L. Chatenoud Cd3-specific antibody-induced active tolerance: from bench to bedside Nat Rev Immunol 3 2003 123 132
49. L. Chatenoud, E. Thervet, J. Primo, and J.F. Bach Anti-cd3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc Natl Acad Sci U S A 91 1994 123 127
50. B. Keymeulen, E. Vandemeulebroucke, A.G. Ziegler, C. Mathieu, L. Kaufman, and G. Hale Insulin needs after cd3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2005 2598 2608
51. M.D. Bellin, F.B. Barton, A. Heitman, J.V. Harmon, R. Kandaswamy, and A.N. Balamurugan Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes Am J Transplant 12 2012 1576 1583
52. M. Belghith, J.A. Bluestone, S. Barriot, J. Megret, J.F. Bach, and L. Chatenoud TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to cd3 in overt autoimmune diabetes Nat Med 9 2003 1202 1208
53. A. Beiras-Fernandez, E. Thein, and C. Hammer Induction of immunosuppression with polyclonal antithymocyte globulins: an overview Exp Clin Transplant 1 2003 79 84
54. L. Genestier, S. Fournel, M. Flacher, O. Assossou, J.P. Revillard, and N. Bonnefoy-Berard Induction of fas (apo-1, cd95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins Blood 91 1998 2360 2368
55. M.C. Michallet, X. Preville, M. Flacher, S. Fournel, L. Genestier, and J.P. Revillard Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 2003 657 662
56. M.S. Zand, T. Vo, J. Huggins, R. Felgar, J. Liesveld, and T. Pellegrin Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways Transplantation 79 2005 1507 1515
57. M. Lopez, M.R. Clarkson, M. Albin, M.H. Sayegh, and N. Najafian A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FOXP3+ regulatory T cells J Am Soc Nephrol 17 2006 2844 2853
58. A. Vergani, F. D'Addio, M. Jurewicz, A. Petrelli, T. Watanabe, and K. Liu A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in nod mice Diabetes 59 2010 2253 2264
59. Y. Li, X.C. Li, X.X. Zheng, A.D. Wells, L.A. Turka, and T.B. Strom Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance Nat Med 5 1999 1298 1302
60. D.M. Rothstein, and M.H. Sayegh T-cell costimulatory pathways in allograft rejection and tolerance Immunol Rev 196 2003 85 108
61. T. Wekerle, J. Kurtz, S. Bigenzahn, Y. Takeuchi, and M. Sykes Mechanisms of transplant tolerance induction using costimulatory blockade Curr Opin Immunol 14 2002 592 600
62. R.D. Molano, T. Berney, H. Li, P. Cattan, A. Pileggi, and C. Vizzardelli Prolonged islet graft survival in nod mice by blockade of the CD40-CD154 pathway of T-cell costimulation Diabetes 50 2001 270 276
63. M.S. Anderson, and J.A. Bluestone The nod mouse: a model of immune dysregulation Annu Rev Immunol 23 2005 447 485
64. M.J. Ansari, P. Fiorina, S. Dada, I. Guleria, T. Ueno, and X. Yuan Role of icos pathway in autoimmune and alloimmune responses in nod mice Clin Immunol 126 2008 140 147
65. S.A. Nanji, W.W. Hancock, B. Luo, C.D. Schur, R.L. Pawlick, and L.F. Zhu Costimulation blockade of both inducible costimulator and cd40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the nod mouse Diabetes 55 2006 27 33
66. T. Berney, A. Pileggi, R.D. Molano, R. Poggioli, E. Zahr, and C. Ricordi The effect of simultaneous cd154 and lfa-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice Transplantation 76 2003 1669 1674
67. I. Guleria, M. Gubbels Bupp, S. Dada, B. Fife, Q. Tang, and M.J. Ansari Mechanisms of pdl1-mediated regulation of autoimmune diabetes Clin Immunol 125 2007 16 25
68. S.E. Sandner, M.R. Clarkson, A.D. Salama, A. Sanchez-Fueyo, C. Domenig, and A. Habicht Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo J Immunol 174 2005 3408 3415
69. A. Citro, E. Cantarelli, P. Maffi, R. Nano, R. Melzi, and A. Mercalli Cxcr1/2 inhibition enhances pancreatic islet survival after transplantation J Clin Invest 122 2012 3647 3651
70. P.T. Walsh, D.K. Taylor, and L.A. Turka Tregs and transplantation tolerance J Clin Invest 114 2004 1398 1403
71. M.R. Nicolls, M. Coulombe, J. Beilke, H.C. Gelhaus, and R.G. Gill Cd4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of cd154 and lfa-1 pathways J Immunol 169 2002 4831 4839
72. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4+CD25+FOXP3+ regulatory t cells Blood 105 2005 4743 4748
73. N. Komatsu, K. Okamoto, S. Sawa, T. Nakashima, M. Oh-Hora, and T. Kodama Pathogenic conversion of FOXP3(+) T cells into Th17 cells in autoimmune arthritis Nat Med 20 2014 62 68
74. N. Gagliani, C.F. Magnani, S. Huber, M.E. Gianolini, M. Pala, and P. Licona-Limon Coexpression of CD49b and lag-3 identifies human and mouse T regulatory type 1 cells Nat Med 19 2013 739 746
75. M.H. Sayegh, and L.A. Turka The role of T-cell costimulatory activation pathways in transplant rejection N Engl J Med 338 1998 1813 1821
76. D. Faustman, V. Hauptfeld, P. Lacy, and J. Davie Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to ia determinants Proc Natl Acad Sci U S A 78 1981 5156 5159
77. P. Fiorina, M. Jurewicz, K. Tanaka, N. Behazin, A. Augello, and A. Vergani Characterization of donor dendritic cells and enhancement of dendritic cell efflux with cc-chemokine ligand 21: a novel strategy to prolong islet allograft survival Diabetes 56 2007 912 920
78. E. Astorri, P. Fiorina, G. Gavaruzzi, A. Astorri, and G. Magnati Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment Cardiology 88 1997 152 155
79. P. Fiorina, G. Lattuada, O. Ponari, C. Silvestrini, and P. DallAglio Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients Lancet 347 1996 692 693
80. A. Vergani, S. Tezza, F. D'Addio, C. Fotino, K. Liu, and M. Niewczas Long-term heart transplant survival by targeting the ionotropic purinergic receptor p2x7 Circulation 127 2013 463 475
81. A. Vergani, C. Fotino, F. D'Addio, S. Tezza, M. Podetta, and F. Gatti Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection Diabetes 62 2013 1665 1675
82. A. Vergani, S. Tezza, C. Fotino, G. Visner, A. Pileggi, and A. Chandraker The purinergic system in allotransplantation Am. J. Transplant. 14 2014 507 514